# Psilocybin for the Treatment of Migraine Headache

> **NCT03341689** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 14 (actual)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** High Dose Psilocybin
- **DRUG:** Low Dose Psilocybin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03341689
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-10-31
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03341689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03341689, "Psilocybin for the Treatment of Migraine Headache". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03341689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*